Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Lancet (London, England)|September 19, 2006
Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trialJiangtao Lin, Jiansan Zhang, Xiaoping Dong, et al.
Respiratory Medicine|April 2, 2018
Prevalence and risk factors of asthma in mainland China: The CARE studyJiangtao Lin, Wenya Wang, Ping Chen, et al.
American Journal of Translational Research|June 22, 2026
Efficacy and safety of chaishituire granules in influenza treatment: a multi-center, randomized, double-blind, parallel-controlled clinical trialYing Nong, Jiangtao Lin, Guang'en Wang, et al.
Respiratory Medicine|July 6, 2021
Effectiveness of omalizumab in patients with severe allergic asthma: A retrospective study in ChinaMin Zhang, Meiling Jin, Xin Zhou, et al.
The Journal of Allergy and Clinical Immunology|May 13, 2023
Identification of cough-variant asthma phenotypes based on clinical and pathophysiologic dataWenzhi Zhan, Feng Wu, Yunhui Zhang, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 31, 2021
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key ChangesHelen K Reddel, Leonard B Bacharier, Eric D Bateman, et al.
Respirology (Carlton, Vic.)|October 20, 2021
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key ChangesHelen K Reddel, Leonard B Bacharier, Eric D Bateman, et al.
Archivos De Bronconeumologia|March 4, 2022
Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key ChangesHelen K Reddel, Leonard B Bacharier, Eric D Bateman, et al.
American Journal of Respiratory and Critical Care Medicine|October 18, 2021
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key ChangesHelen K Reddel, Leonard B Bacharier, Eric D Bateman, et al.
Pageof 12